1. Home
  2. ANIX vs SNCR Comparison

ANIX vs SNCR Comparison

Compare ANIX & SNCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ANIX
  • SNCR
  • Stock Information
  • Founded
  • ANIX 1982
  • SNCR 2000
  • Country
  • ANIX United States
  • SNCR United States
  • Employees
  • ANIX N/A
  • SNCR N/A
  • Industry
  • ANIX Biotechnology: Pharmaceutical Preparations
  • SNCR EDP Services
  • Sector
  • ANIX Health Care
  • SNCR Technology
  • Exchange
  • ANIX Nasdaq
  • SNCR Nasdaq
  • Market Cap
  • ANIX 87.1M
  • SNCR 85.8M
  • IPO Year
  • ANIX 1987
  • SNCR 2006
  • Fundamental
  • Price
  • ANIX $2.94
  • SNCR $9.47
  • Analyst Decision
  • ANIX Strong Buy
  • SNCR
  • Analyst Count
  • ANIX 1
  • SNCR 0
  • Target Price
  • ANIX $7.00
  • SNCR N/A
  • AVG Volume (30 Days)
  • ANIX 70.2K
  • SNCR 38.7K
  • Earning Date
  • ANIX 09-04-2024
  • SNCR 08-06-2024
  • Dividend Yield
  • ANIX N/A
  • SNCR N/A
  • EPS Growth
  • ANIX N/A
  • SNCR N/A
  • EPS
  • ANIX N/A
  • SNCR N/A
  • Revenue
  • ANIX N/A
  • SNCR $149,453,000.00
  • Revenue This Year
  • ANIX N/A
  • SNCR $7.65
  • Revenue Next Year
  • ANIX N/A
  • SNCR $5.08
  • P/E Ratio
  • ANIX N/A
  • SNCR N/A
  • Revenue Growth
  • ANIX N/A
  • SNCR N/A
  • 52 Week Low
  • ANIX $2.15
  • SNCR $2.70
  • 52 Week High
  • ANIX $5.13
  • SNCR $13.97
  • Technical
  • Relative Strength Index (RSI)
  • ANIX 60.32
  • SNCR 53.06
  • Support Level
  • ANIX $2.85
  • SNCR $9.13
  • Resistance Level
  • ANIX $3.44
  • SNCR $10.02
  • Average True Range (ATR)
  • ANIX 0.21
  • SNCR 0.77
  • MACD
  • ANIX 0.09
  • SNCR 0.05
  • Stochastic Oscillator
  • ANIX 60.94
  • SNCR 33.00

About ANIX Anixa Biosciences Inc.

Anixa Biosciences Inc, a cancer-focused biotechnology company, developing vaccines and therapies that are focused on critical unmet needs in oncology. The company is developing both diagnostics and therapeutics to detect cancer early, which is curable, and to treat those afflicted once diagnosed. Its segment includes CAR-T Therapeutics; Cancer Vaccines; Anti-Viral Therapeutics and others.

About SNCR Synchronoss Technologies Inc.

Synchronoss Technologies Inc is a leading provider of white-label cloud, messaging, digital and network management solutions that enable its customers to keep subscribers, systems, networks and content in sync. The Synchronoss Personal CloudTM solution is designed to create an engaging and trusted customer experience through ongoing content management and engagement. The Synchronoss Personal CloudTM platform is a secure and highly scalable, white-label platform that allows its customers' subscribers to backup and protect, engage with, and manage their personal content. The company derives revenue from subscriptions and transaction-based fees. A majority of the firm's revenue is generated in the United States, and the rest is from countries across the world.

Share on Social Networks: